Company: OXBRW
Filing Date: 2025-08-07
Form Type: DEF 14A
Source: 0001641172-25-022627
Chunk: 8

Company: OXBRIDGE RE HOLDINGS Ltd
Filing Date: 2025-08-07
Form: DEF 14A
Chunk 8
---
 US$0.001 each. The Board unanimously approved the proposed increase and declared it to be advisable and in the best interest of our Company and our shareholders, and hereby seeks the approval by our shareholders of the amendment to the Company’s authorized share capital through passage of an ordinary resolution.

Purpose and Possible Effect

Over the past year, we have used our ordinary shares to, among other things, engage in at-the-market equity offering programs (including our existing at-the-market equity offering program) and incentivize and compensate our employees, Board members and external consultants by issuing equity awards exercisable or settleable in ordinary shares. We anticipate that we may issue additional ordinary shares and securities or equity awards which may be convertible, exercisable or otherwise settleable in ordinary shares in the future in connection with one or more of the following:

| ● | financing                                                                                                                              
 transactions, such as public or private offerings of ordinary shares or securities which may be convertible, exercisable or otherwise  
 settleable in our ordinary shares;                                                                                                     |
| ● | sales                                                                                                                                  
 under our existing and any future at-the-market equity offering program;                                                               |
| ● | employee                                                                                                                               
 incentives and compensation through our equity incentive plans;                                                                        |
| ● | settlement                                                                                                                             
 of redemptions and/or conversions of other securities which may be convertible, exercisable or otherwise settleable in ordinary shares 
 that we may issue in the future; and                                                                                                   |
| ● | for                                                                                                                                    
 other corporate purposes that have not yet been identified.                                                                            |

Any newly authorized ordinary shares will be identical to the ordinary shares now authorized and outstanding. The proposed share capital increase will not alter the voting powers or relative rights of the ordinary shares. Adoption of the share capital increase will have no immediate dilutive effect on the proportionate voting power or other rights of the Company’s existing shareholders. The Board has no current plan to issue shares from the additional authorized shares provided by the share capital increase. However, any future issuance of additional authorized ordinary shares may, among other things, dilute the earnings per share of our ordinary shares and the equity and voting rights of those holding ordinary shares at the time the additional shares are issued. Additionally, this potential dilutive effect may cause a reduction in the market price of our ordinary shares.

By increasing the number of authorized but unissued ordinary shares, our ability to issue additional ordinary shares could, under certain circumstances, have an anti-takeover effect, although this is not the intent of the Board. For example, our ability to issue additional ordinary shares could